FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093019991> ?p ?o ?g. }

• W2093019991 endingPage "461" @default.
• W2093019991 startingPage "455" @default.
• W2093019991 abstract "Objective Angiotensin II type 1 receptor blocker (ARB) is increasingly prescribed for the treatment of systolic heart failure with a growing body of clinical evidence. The roles of ARB, however, remain to be clarified in the treatment of diastolic heart failure (DHF), particularly at its advanced stage. This experimental study investigated the effects of ARB administered at an advanced stage of hypertensive DHF. Methods Dahl salt-sensitive rats fed an 8% NaCl diet from age 7 weeks represent overt DHF at age 20 weeks, as noted in previous studies (hypertensive DHF model). The DHF model rats were randomly divided into two groups at age 17 weeks when left ventricular diastolic dysfunction, hypertrophy, fibrosis, macrophage infiltration and reactive oxygen species generation were already augmented; six rats treated for 3 weeks with a subdepressor dose of ARB (olmesartan 0.6 mg/kg per day), and six untreated rats. Results The 3-week administration of ARB significantly decreased the left ventricular end-diastolic pressure in association with attenuation of left ventricular hypertrophy, fibrosis and diastolic dysfunction. Macrophage infiltration was attenuated with decreased gene expression of transforming growth factor-β1 and monocyte chemoattractant protein-1 in the left ventricular myocardium of the ARB-treated rats. The production of reactive oxygen species also decreased with NADPH oxidase activity. Conclusions ARB provides beneficial effects in hypertensive DHF independent of its antihypertensive effects even if initiated at an advanced stage. The beneficial effects are at least partly attributed to the attenuation of inflammatory changes and oxidative stress through the suppression of cytokine and chemokine production and of NADPH oxidase activity." @default.
• W2093019991 created "2016-06-24" @default.
• W2093019991 creator A5009840124 @default.
• W2093019991 creator A5016381993 @default.
• W2093019991 creator A5018573172 @default.
• W2093019991 creator A5025153902 @default.
• W2093019991 creator A5033804823 @default.
• W2093019991 creator A5045956357 @default.
• W2093019991 creator A5049340312 @default.
• W2093019991 creator A5064738789 @default.
• W2093019991 creator A5078287634 @default.
• W2093019991 creator A5083909742 @default.
• W2093019991 date "2007-02-01" @default.
• W2093019991 modified "2023-10-02" @default.
• W2093019991 title "Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure" @default.
• W2093019991 cites W1547783254 @default.
• W2093019991 cites W1921122469 @default.
• W2093019991 cites W1967970013 @default.
• W2093019991 cites W1969098967 @default.
• W2093019991 cites W1999635340 @default.
• W2093019991 cites W2001927282 @default.
• W2093019991 cites W2007274732 @default.
• W2093019991 cites W2015505701 @default.
• W2093019991 cites W2026153977 @default.
• W2093019991 cites W2037749195 @default.
• W2093019991 cites W2039502266 @default.
• W2093019991 cites W2055227028 @default.
• W2093019991 cites W2056893352 @default.
• W2093019991 cites W2075868324 @default.
• W2093019991 cites W2087324240 @default.
• W2093019991 cites W2090016088 @default.
• W2093019991 cites W2098780362 @default.
• W2093019991 cites W2105161080 @default.
• W2093019991 cites W2106909429 @default.
• W2093019991 cites W2108246384 @default.
• W2093019991 cites W2109281287 @default.
• W2093019991 cites W2110676635 @default.
• W2093019991 cites W2128306809 @default.
• W2093019991 cites W2128929076 @default.
• W2093019991 cites W2134743993 @default.
• W2093019991 cites W2135624975 @default.
• W2093019991 cites W2137403077 @default.
• W2093019991 cites W2143756095 @default.
• W2093019991 cites W2160950754 @default.
• W2093019991 cites W3021063182 @default.
• W2093019991 doi "https://doi.org/10.1097/hjh.0b013e328010d635" @default.
• W2093019991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17211254" @default.
• W2093019991 hasPublicationYear "2007" @default.
• W2093019991 type Work @default.
• W2093019991 sameAs 2093019991 @default.
• W2093019991 citedByCount "37" @default.
• W2093019991 countsByYear W20930199912012 @default.
• W2093019991 countsByYear W20930199912013 @default.
• W2093019991 countsByYear W20930199912014 @default.
• W2093019991 countsByYear W20930199912015 @default.
• W2093019991 countsByYear W20930199912016 @default.
• W2093019991 countsByYear W20930199912017 @default.
• W2093019991 countsByYear W20930199912019 @default.
• W2093019991 countsByYear W20930199912020 @default.
• W2093019991 countsByYear W20930199912021 @default.
• W2093019991 crossrefType "journal-article" @default.
• W2093019991 hasAuthorship W2093019991A5009840124 @default.
• W2093019991 hasAuthorship W2093019991A5016381993 @default.
• W2093019991 hasAuthorship W2093019991A5018573172 @default.
• W2093019991 hasAuthorship W2093019991A5025153902 @default.
• W2093019991 hasAuthorship W2093019991A5033804823 @default.
• W2093019991 hasAuthorship W2093019991A5045956357 @default.
• W2093019991 hasAuthorship W2093019991A5049340312 @default.
• W2093019991 hasAuthorship W2093019991A5064738789 @default.
• W2093019991 hasAuthorship W2093019991A5078287634 @default.
• W2093019991 hasAuthorship W2093019991A5083909742 @default.
• W2093019991 hasConcept C126322002 @default.
• W2093019991 hasConcept C134018914 @default.
• W2093019991 hasConcept C164705383 @default.
• W2093019991 hasConcept C167414201 @default.
• W2093019991 hasConcept C2776002628 @default.
• W2093019991 hasConcept C2778198053 @default.
• W2093019991 hasConcept C2779766728 @default.
• W2093019991 hasConcept C2779781611 @default.
• W2093019991 hasConcept C2780559512 @default.
• W2093019991 hasConcept C2908929049 @default.
• W2093019991 hasConcept C57900726 @default.
• W2093019991 hasConcept C71924100 @default.
• W2093019991 hasConcept C84393581 @default.
• W2093019991 hasConceptScore W2093019991C126322002 @default.
• W2093019991 hasConceptScore W2093019991C134018914 @default.
• W2093019991 hasConceptScore W2093019991C164705383 @default.
• W2093019991 hasConceptScore W2093019991C167414201 @default.
• W2093019991 hasConceptScore W2093019991C2776002628 @default.
• W2093019991 hasConceptScore W2093019991C2778198053 @default.
• W2093019991 hasConceptScore W2093019991C2779766728 @default.
• W2093019991 hasConceptScore W2093019991C2779781611 @default.
• W2093019991 hasConceptScore W2093019991C2780559512 @default.
• W2093019991 hasConceptScore W2093019991C2908929049 @default.
• W2093019991 hasConceptScore W2093019991C57900726 @default.
• W2093019991 hasConceptScore W2093019991C71924100 @default.
• W2093019991 hasConceptScore W2093019991C84393581 @default.
• W2093019991 hasIssue "2" @default.

• next